JPH01294637A - Method and apparatus for collecting immune antibody and complement - Google Patents

Method and apparatus for collecting immune antibody and complement

Info

Publication number
JPH01294637A
JPH01294637A JP12487188A JP12487188A JPH01294637A JP H01294637 A JPH01294637 A JP H01294637A JP 12487188 A JP12487188 A JP 12487188A JP 12487188 A JP12487188 A JP 12487188A JP H01294637 A JPH01294637 A JP H01294637A
Authority
JP
Japan
Prior art keywords
urine
complement
pathogens
infected
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP12487188A
Other languages
Japanese (ja)
Inventor
Tetsuo Takano
高野 鉄雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP12487188A priority Critical patent/JPH01294637A/en
Publication of JPH01294637A publication Critical patent/JPH01294637A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE:To provide an immune antibody and a complement useful for the treatment of man infected with pathogens by removing the pathogens form urine collected from the infected man himself or any other man infected with the same pathogens or subjecting the urine to an inactivation treatment. CONSTITUTION:Urine is collected from an infected man himself or any other man or animal infected with the same pathogens. The collected urine is filtered with a filtering material capable of removing the pathogens or the pathogens in the urine are inactivated with a physical or chemical treatment capable of being carried out without damaging the immune antibody and complement. The treated urine is further passed through a dialyzing apparatus capable of removing urea during or after the aforementioned treatment to diffuse and remove the urea, thus collecting the immune antibody and complement.

Description

【発明の詳細な説明】 (産業上の利用分野) この発明はウィルス、細菌、微生物、その他の病原体に
感染した人の治療に役立つ免疫抗体の採取法と採取装置
に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a method and apparatus for collecting immune antibodies useful for treating people infected with viruses, bacteria, microorganisms, and other pathogens.

〈従来の技術〉 現代医学は一部の細菌に対して直接作用する抗生物質等
の特効薬を開発し、その細菌の感染者に福音をもたらし
た。しかし特効薬が未開発の細菌、特効薬が効かなくな
った耐性菌、微生物、そしてすべての病原ウーイルスに
対して、現代医学は無力に近い、対症治療を加えつつ、
患者自身の自然治癒力に任せているのが、一般医療の現
状である。
<Conventional technology> Modern medicine has developed special drugs such as antibiotics that act directly against some bacteria, and has brought good news to those infected with those bacteria. However, modern medicine is nearly powerless against bacteria for which specific drugs have not yet been developed, resistant bacteria and microorganisms for which specific drugs are no longer effective, and all pathogenic viruses, while adding symptomatic treatment.
The current state of general medical care is to leave it to the patient's own natural healing power.

生理学、病理学では1人体の自然治癒力が相出、解明さ
れて来た。
In physiology and pathology, the natural healing power of the human body has been discovered and elucidated.

すなわち、動物か病原体の侵入(感染)を受けると、細
胞性および体液性免疫反応を生ずる。前者は白血球、マ
クロファージ等の細胞がその病原体への攻撃力を強める
反応であり、後者は血漿中に、その病原体に有効な免疫
抗体を生ずる反応で、これらが感染者の自然治癒力とな
ている。
That is, when an animal is invaded (infected) by a pathogen, it produces cellular and humoral immune responses. The former is a reaction in which cells such as white blood cells and macrophages strengthen their attack power against the pathogen, and the latter is a reaction in which antibodies that are effective against the pathogen are generated in the plasma, and these act as the infected person's natural healing power. There is.

この自然治癒力を人為的に強める方法として従来は、特
定病原体に感染した人か動物の血から採った免疫血清を
検査、治療に用いる方法と、弱めた病原体を予め与えて
、感染前に免疫力を強めておくワクチン、またはそのワ
クチンを上記免疫血清に加えて治療に用いる方法がある
だけのようである。
Conventionally, methods to artificially strengthen this natural healing power include using immune serum taken from the blood of a person or animal infected with a specific pathogen for testing and treatment, or by giving weakened pathogens in advance to provide immunity before infection. It seems that there is only a way to use a vaccine with increased potency or to add the vaccine to the above immune serum for treatment.

また、この発明のヒントになった東洋医学、民間療法の
尿療法は、「自分の尿を飲んで難病を治す」、「毎日、
湯呑み−ばい尿をそのまま飲む、自分の尿だから害かな
い」というものである。
In addition, the oriental medicine and folk medicine urinary therapy that inspired this invention include ``drinking your own urine to cure incurable diseases'' and ``every day.
Teacup - drink the urine as it is, it's your own urine so it won't harm you.''

〈発明か解決しようとする課題〉 特効薬のない病原体に感染した患者は、対症治療しつつ
自然治癒を待つたけ、という一般医療の現状を打開する
事、新規、な自然治癒力増強手段を提供する事が、この
発明の目的である。
<Problem to be solved by the invention> To overcome the current state of general medical care, where patients infected with pathogens for which there are no specific drugs are treated symptomatically and wait for natural recovery, and to provide a new means of enhancing natural healing power. This is the purpose of this invention.

〈課題を解決するための手段〉 第1発明の免疫抗体、補体の採取法は、感染者自身か、
同じ病原体に感染した他人か動物の尿を採り、その尿を
、上記病原体を除去てきる濾材で濾過することを特徴と
する。
<Means for solving the problem> The method for collecting immune antibodies and complement of the first invention is based on the method of collecting immune antibodies and complements from the infected person himself or herself.
It is characterized by collecting the urine of another person or animal infected with the same pathogen and filtering the urine through a filter medium that can remove the pathogen.

第2発明の免疫抗体、補体の採取法は、感染者自身か、
同じ病原体に感染した他人か動物の尿を取り、その尿中
の上記病原体を、免疫抗体、補体な損わないで行い得る
物理的、または化学的処理により、不活性化することを
特徴とする。
The immune antibody and complement collection method of the second invention is based on
It is characterized by taking the urine of another person or animal infected with the same pathogen and inactivating the pathogen in the urine by physical or chemical treatment that can be performed without damaging immune antibodies or complement. do.

第3発明の免疫抗体、補体の採取法は、請求項(1)ま
たは請求項(2)に記載の方法の途中、または終りに、
その尿を、尿素を除去し得る透析装置に通すことを特徴
とする。
The immune antibody and complement collection method of the third invention includes, during or at the end of the method according to claim (1) or claim (2),
It is characterized by passing the urine through a dialysis machine that can remove urea.

第4発明の免疫抗体、補体の採取装置は゛、尿の供給口
をもち、尿中の細菌、またはウィルスまて除去し得る濾
材を使った濾過装置、及び上記濾過装置から出た尿を通
すことにより、尿中の尿素を拡散除去し得る透析装置、
を備えることを特徴とする。
The immune antibody and complement collection device of the fourth invention comprises a filtration device that has a urine supply port and uses a filtering medium capable of removing bacteria or viruses in the urine, and a filtration device that allows the urine discharged from the filtration device to pass through. A dialysis device capable of diffusing and removing urea in urine,
It is characterized by having the following.

〈作 用〉 この発明は東洋医学、民間療法として古くからある尿療
法を近代生理学により解明し、その欠点を解消し、尿を
免疫抗体、補体の採取源とする道を開いた。
<Function> This invention has elucidated the ancient method of urinary therapy in Oriental medicine and folk medicine using modern physiology, eliminated its drawbacks, and opened the way to use urine as a source for collecting immune antibodies and complement.

従来、医学者が民間の尿療法を真剣に取上げなかったの
は、多分、尿中の免疫抗体、補体はウィルスの十分の一
程度の大きさのため、電子顕微鏡でもとらえ難く、培養
、増殖はできないから、その存在を確認する方法が無か
ったためと思われる。また生理作用で血液中の不要物を
尿として排出しているのに、その尿を飲んで血液中へ戻
し、生理作用の流れを乱すのは、特に体力の弱った患者
にすすめられる事でなく、効果かあるとすれば、汚い尿
を飲むという信仰心の精神作用でないか、という医学者
の考えによるかも知れない。そして尿療法を患者にすす
めて成功しても、医師の収入にも、手からにもならない
事も、意欲を殺いでいるかと思われる。
The reason why medical scientists have not seriously taken up folk urine therapy in the past is probably because immune antibodies and complement in urine are about one-tenth the size of viruses, making them difficult to detect even with an electron microscope. This is probably because there was no way to confirm its existence. Furthermore, although unnecessary substances in the blood are excreted as urine due to physiological processes, it is not recommended for patients who are particularly physically weak to drink that urine and return it to the blood, thereby disrupting the flow of physiological processes. If there is any effect, it may be due to the belief of medical scientists that it may be due to the psychological effect of the religious feeling of drinking dirty urine. Furthermore, even if urine therapy is successfully recommended to patients, the fact that it does not generate any income or profits for the doctor seems to be killing their motivation.

尿中に免疫抗体、補体が含まれている事を確認できない
から、民間の尿療法を取上げないとすれば非科学的であ
る。
It would be unscientific to not discuss folk urine therapy because it cannot be confirmed that urine contains immune antibodies and complement.

この発明は現代生理学にもとづき、尿中に免疫抗体、補
体が含まれている必然性を立証し、また従来の尿療法の
欠点を明らかにする。
This invention is based on modern physiology, proves the necessity for urine to contain immune antibodies and complement, and also clarifies the shortcomings of conventional urine therapy.

まず上記の必然性であるが、動物か病原体に感染すると
血液中に免疫抗体が出てくる事は広く認められている。
First of all, regarding the necessity mentioned above, it is widely accepted that when an animal is infected with a pathogen, immune antibodies are produced in the blood.

その抗体が食細胞や補体の応援を得て病原体を殺すか、
包みこむ事も周知である。
Whether the antibody kills the pathogen with the support of phagocytes and complement,
It is also well known to envelop.

殺すか包みこまれた病原体は当然、体外へ搬出するので
あるが、体外へ搬出する手段は糞便か尿に入れるほかな
い。組織の患部で殺されるか、包みこまれた病原体はリ
ンパ管、血管内を運ばれ腎臓に達する。腎臓の働きは濾
過、吸収な繰返えす複雑、不可解なものであるか結果的
には血液で運ばれた老廃物、過剰物、異物そして病原体
も、大量の血漿と共に尿として排出する。殺されるか包
みこまれた病原体には、周知のように免疫抗体、補体が
群り付いている事、腎臓の濾過機能は比較的大まかな事
を考えれば、尿中に抗体、補体か出るのは必然である。
Naturally, pathogens that have been killed or encapsulated must be transported out of the body, but the only way to transport them out of the body is through feces or urine. Pathogens that are killed or encapsulated in the affected tissue are transported in the lymphatic and blood vessels to the kidneys. The function of the kidneys is complicated and mysterious, as it repeats filtration and absorption, and as a result, waste products, excess substances, foreign substances, and pathogens carried in the blood are excreted in the urine along with large amounts of plasma. As is well known, pathogens that have been killed or encapsulated are swarmed with immune antibodies and complement, and given that the kidney's filtration function is relatively rough, antibodies and complement can be found in urine. It is inevitable that it will come out.

以上により感染者の尿中には、感染源である病原体に対
応して産生された免疫抗体と、戦いに参加した補体とか
存在する事は理論上、確実である。
Based on the above, it is theoretically certain that antibodies produced in response to the pathogen that caused the infection and complement that participated in the fight are present in the urine of an infected person.

尿中に出てきた抗体、補体は病原体を攻撃した弾丸のよ
うな消耗品と考えられるから、これを回収して体内へ戻
しても、直ちに有効な戦力にならないかも知れない。し
かし、破損した抗体、補体でも、体内に吸収されればリ
ンパ節、ひ臓、骨髄等の抗体産生組織へ送られ、速やか
に完全な形に戻されるてあろう。民間療法の否定し難い
治療効果は、抗体、補体な含む本人の尿を飲むことによ
り、その抗体、補体が血漿中へ戻って、同種病原体の攻
撃に参加するため、と考えるほかない。
Antibodies and complements released in urine can be thought of as consumables, like bullets that attack pathogens, so even if they are collected and returned to the body, they may not immediately become an effective fighting force. However, even if damaged antibodies and complement are absorbed into the body, they will be sent to antibody-producing tissues such as lymph nodes, spleen, and bone marrow, where they will be quickly restored to their complete form. The undeniable therapeutic effect of folk remedies can only be attributed to the fact that by drinking the patient's own urine, which contains antibodies and complement, those antibodies and complement return to the plasma and participate in the attack of the same pathogen.

血漿中の免疫抗体の働きは多岐にわたるようで、文献に
よれば、可溶抗原(病原体)を沈降させ、粒子状抗原を
凝集させ、細菌に対する食作用を増進し、毒素を中和し
、感受性をもつ細菌、細胞を崩壊させる、とある。定義
として「抗体とは抗原と特異的に反応する物質の総称で
ある」となっている、これから考えると、抗体、補体が
集っても病原体を完全に殺して運び出す事はむしろ少な
く、まだ生きている病原体が尿へ出てくる場合か多いて
あろう。
The functions of immune antibodies in plasma seem to be diverse, and according to the literature, they precipitate soluble antigens (pathogens), aggregate particulate antigens, promote phagocytosis of bacteria, neutralize toxins, and increase susceptibility. It says that bacteria with this type of bacteria cause cell collapse. The definition is, ``Antibody is a general term for substances that react specifically with antigens.'' Considering this, even if antibodies and complements gather, it is rather unlikely that they will completely kill and transport pathogens; In many cases, live pathogens may be excreted in the urine.

これか従来の尿療法の欠点で、抗体、補体を再利用する
代償として、生きた病原体も体内へ戻してしまうのであ
る。
This is another disadvantage of conventional urine therapy, which returns live pathogens to the body at the cost of recycling antibodies and complement.

さらに見逃がせない従来の尿療法の欠点は、腎炎、腎う
炎、ぼうこう炎の感染症にかかりやすい尿路な通るため
、尿に新たな病原体が加わりやすい点である。
Another disadvantage of conventional urine therapy that cannot be overlooked is that it passes through the urinary tract, which is susceptible to infections such as nephritis, pyelitis, and cystitis, making it easy for new pathogens to be added to the urine.

この発明は感染者の尿を採った後、その尿中の、組織か
ら搬出された病原体も、尿路から加わった病原体も、す
べて濾過により除去するか(第1発明)、あるいは抗体
、補体を損なわない物理、化学処理により不活性化して
しまう(第2発明)。これで従来療法の最大の欠点は解
消した。
This invention involves collecting the urine of an infected person and removing all pathogens in the urine, including those carried out from the tissues and those added from the urinary tract (first invention), or by removing antibodies and complement. (Second invention). This eliminates the biggest drawback of conventional therapy.

こうして採取した尿は、尿素等、それ自体は無害の老廃
物を多量に含む点を除けば、抗体、補体を含む血漿に等
しい機能をもち、同じ病原体の患者に投与すれば、体内
の抗体、補体を一挙に増強し得る。
The urine collected in this way has the same function as plasma, which contains antibodies and complement, except that it contains a large amount of waste products such as urea, which are harmless in themselves. , can enhance complement all at once.

第1、第2発明により採取した尿は、病原体を除去、ま
たは不活性化しているが、尿素等の老廃物を多量に含ん
でいるため、無制限に投与すれば腎臓の負担を増し、尿
素の血中濃度上昇により、体の不調を生ずる。これは従
来の尿療法の欠点でもある。腎臓自体は片側たけでも足
りるほど処理能力に余裕をもっているか、突然の尿素濃
度上昇には対処か遅れる可能性か少なくない。
Although the urine collected according to the first and second inventions has removed or inactivated pathogens, it contains a large amount of waste products such as urea. Increased blood concentration causes physical discomfort. This is also a drawback of conventional urine therapy. Either the kidney itself has sufficient processing capacity to handle the problem even if only one side is affected, or there is a possibility that there will be a delay in dealing with the sudden increase in urea concentration.

この問題を解消したのか第3発明である。すなわち第1
.第2発明で採取、処理した尿を、途中または最終的に
透析装置に通し、腎臓病患者の人工透析のように、尿中
の尿素を拡散除去する。これで尿中の尿素は十分薄めら
れ、もはや尿とはいえず、血漿に近い成分の液となる。
The third invention seems to have solved this problem. That is, the first
.. The urine collected and processed in the second invention is passed through a dialysis machine either midway or finally, and urea in the urine is diffused and removed, similar to artificial dialysis for kidney disease patients. This dilutes the urea in the urine enough that it can no longer be called urine, but a liquid with components similar to plasma.

なお、従来の尿療法の詳細と、この発明の濾過、透析を
可能にした各種病原体と抗体、補体の寸法差、尿素の寸
法は次項に記す。
The details of conventional urine therapy, the size differences between various pathogens, antibodies, and complement, and the size of urea that made the filtration and dialysis of the present invention possible are described in the next section.

第4発明は第3発明の採取法を実施する装置を示す。A fourth invention provides an apparatus for carrying out the sampling method of the third invention.

〈実 施 例〉 まず従来、民間で行われていた尿療法の最新情報の一例
として、雑誌「壮快」の昭和63年4月号に載った医師
、中尾良−氏の手記の抜粋を次に示す。
<Example> First, as an example of the latest information on urinary therapy conventionally practiced in the private sector, the following is an excerpt from a memo by doctor Ryo Nakao that was published in the April 1986 issue of the magazine ``Sokai''. show.

[淋病の患者の場合] 「次の日の朝、私にいわれたとおりコツプ−杯の尿を飲
んだところ、その夜から、小便が出るときの尿道の焼き
つくような痛みが消失したというのです。
[In the case of gonorrhea patients] ``The next morning, I drank a cup of urine as I was told, and from that night on, the burning pain in my urethra when I urinated disappeared. is.

この患者はその後二、三日で、さしも頑固な淋病が完全
に治癒したのでした。」 [ヘルペスにかかった医師仲間の手紙]「ヘルペス・ツ
オステル(帯状庖疹)にて三週間ばかり悩まされている
最中、甲府の中尾兄より電話、バルン(尿)を飲め、と
、その甘言にのせられ、苦しみのあまり清水の舞台より
飛び降りる覚悟て、自分のを飲みました。忽然と回復!
参りましたね、しかも左足母指(親指)の痛風まで治り
ました。いやでも中尾兄に脱帽です。」[リウマチの患
者(医師)自身のカルテ]「−回の飲尿は180m1 
、初日は二回、二日目より一回、痛みは一回で好転、尿
量増加。上回の服用により庖疹は治癒。同時に前々から
あった左足母指の痛風が快癒したことは予期していなか
った。」 これは医師の手記であり、二人の患者は医師仲間である
から信頼できる。もっとも効かなかった例や、害になっ
た例も時にはあるのではないかと思われるが、その資料
はない。
Within two or three days, this patient was completely cured of his stubborn gonorrhea. ” [Letter from a fellow doctor who contracted herpes] “While I was suffering from herpes zoster (herpes zoster) for about three weeks, I received a phone call from Nakao-nii from Kofu, telling me to drink balun (urine). I drank mine, prepared to jump off the stage in Shimizu in agony.I suddenly recovered!
What's more, the gout in my left big toe has also been cured. No, but hats off to Nakao-nii. ” [Rheumatology patient (doctor’s own medical record)] “- times of urine drinking was 180 m1
, twice on the first day, once on the second day, the pain improved once, and the urine output increased. The herpes rash was cured by taking the above dose. What I didn't expect was that at the same time, the gout in my left big toe, which I had been suffering from for a long time, started to heal. ” This is a doctor's note, and the two patients are fellow doctors, so they can be trusted. I think there may be some cases where it didn't work or caused harm, but I don't have any data on that.

さて図面に示すのは第3発明の採取方法を実施するため
の第4発明の実施例である。その透析装置3を取り外し
、濾過装!t2から直接、受はカップ4へ液を落とせば
、第1発明の採取法も実施できる。
Now, what is shown in the drawings is an embodiment of the fourth invention for carrying out the sampling method of the third invention. Remove the dialysis device 3 and use the filtration device! If the receiver drops the liquid directly into the cup 4 from t2, the collection method of the first invention can also be carried out.

図の1は尿供給口で、少くとも180m1の尿を蓄えら
れる容量をもつ。2は濾過装置で、濾材としては細菌も
ウィルスも除去できるのものとして、再生セルローズか
ら作る多孔性中空糸膜を使っている。この中空糸膜の寸
法は外径240〜300pm、内径200〜210 g
m、 119425〜30gmで、この膜厚中に200
〜300人の膜か100〜150層に多層化されている
。膜には1 cya”あたり10億個の穴がおいており
、−層一層の膜で順次ウィルスを捕えて完全分離する。
1 in the figure is the urine supply port, which has a capacity to store at least 180ml of urine. 2 is a filtration device, which uses a porous hollow fiber membrane made from recycled cellulose as a filter material that can remove both bacteria and viruses. The dimensions of this hollow fiber membrane are an outer diameter of 240 to 300 pm and an inner diameter of 200 to 210 g.
m, 119425~30 gm, and 200 gm in this film thickness.
It is multi-layered with ~300 people or 100-150 layers. The membrane has 1 billion holes per 1 cya, and each layer of the membrane sequentially traps viruses and completely separates them.

超多段層にすることにより完全分離を可能にしたもので
ある。
Complete separation is made possible by using ultra-multilayered layers.

濾過速度は人工腎臓のそれの数百倍になる。素材の再生
セルローズは蛋白質の吸着性がないため穴の目詰りを起
こさない、しかもアルブミン、免疫グロブリン(抗体)
など有用蛋白質の膜透過性がよい濾材である。
The filtration rate will be hundreds of times faster than that of an artificial kidney. The recycled cellulose material does not absorb proteins, so it does not clog the holes, and it also absorbs albumin and immunoglobulins (antibodies).
It is a filter material with good membrane permeability for useful proteins such as

なお参考のため血液中の各成分の大きさを数値の桁で示
すと、赤血球は10−61、細菌は10−’m、ウィル
スは10−’m〜1G−’m 、免疫抗体(グロブリン
)は10−9mである。尿素と補体の寸法は文献に見え
ないので1分子量で上記抗体と比較すると、抗体の分子
量16〜19万、補体の分子量6〜59万に対し、尿素
の分子量は僅か60.1である。
For reference, the size of each component in blood is shown in numerical digits: red blood cells are 10-61, bacteria are 10-'m, viruses are 10-'m to 1G-'m, and immune antibodies (globulins). is 10-9 m. The dimensions of urea and complement cannot be found in the literature, so if we compare them with the above antibody in terms of molecular weight, the molecular weight of the antibody is 160,000 to 190,000, and the molecular weight of complement is 60,000 to 590,000, whereas the molecular weight of urea is only 60.1. .

これにより、第1発明で用いる濾材の穴口は、感染した
病原体が細菌であれば10−’sのもの、ウィルスであ
れば10−’mのものを使う。いずれの場合も、尿路感
染症により尿路て加わる菌を排除できる寸法である。
Accordingly, the hole opening of the filter medium used in the first invention is 10-'s if the infected pathogen is a bacteria, and 10-'m if the infected pathogen is a virus. In either case, the size is such that bacteria that enter the urinary tract due to a urinary tract infection can be eliminated.

図の鑓過装N2の下に透析装置3の上端の尿量入口が接
続している。尿供給口lから降下し、濾過装置2内の濾
材を通過する間に病原体を除かれた尿は、直ちに透析装
置3の上方に入る。
The urine flow inlet at the upper end of the dialysis device 3 is connected below the filter N2 in the figure. Urine that descends from the urine supply port 1 and from which pathogens have been removed while passing through the filter medium in the filtration device 2 immediately enters the upper part of the dialysis device 3 .

透析装置3は血液透析用の既製品を用いる。これには何
十種類とあり、コイル型、積層型、中空繊維型の三つに
大別される。コイル型は細長い封筒のような膜を巻紙状
に巻き、上下開封された封筒の中に血液(この発明では
尿)、外側に透析液(通常、水)を流す。
The dialysis device 3 uses a ready-made product for hemodialysis. There are dozens of types, and they are roughly divided into three types: coil type, laminated type, and hollow fiber type. In the coil type, a long, thin envelope-like membrane is rolled into a rolling paper, and blood (in this invention, urine) flows into the envelope, which is opened at the top and bottom, and dialysate (usually water) flows outside.

積層型はサンッドイッチのように何枚もの封筒を積み重
ねた感じのもの、中空繊維型は毛細ガラス管を束にした
ものである。
The laminated type looks like a stack of envelopes like a sandwich, and the hollow fiber type has a bundle of capillary glass tubes.

これらの量産品または注文製作の血液透析器の血液側に
尿を入れ、透析液側に水を送ると、両側の濃度差により
、尿中の尿素か半透膜(セロファン等の高分子膜)を浸
透、拡散して透析液である水に溶は出てくるから、その
水を捨てればよい。
When urine is put into the blood side of these mass-produced or custom-made hemodialyzers and water is sent to the dialysate side, due to the concentration difference between both sides, urea in the urine or a semi-permeable membrane (polymer membrane such as cellophane) The solution penetrates and diffuses into the dialysate water, so you can just throw that water away.

図の実施例では、水道蛇口8の下に水槽9を固定し、水
4119の水をホース10により透析装置3の透析液(
水)入口3aへ降下させ、上方の出口3bからホース1
0’により排水溝へ向けている。
In the illustrated embodiment, a water tank 9 is fixed under the water faucet 8, and the dialysate (
water) descend to the inlet 3a, and from the upper outlet 3b the hose 1
0' points toward the drain.

図の実施例装置は一般家庭用として、最も簡素に構球し
たもので、受はカップ4を載せた基台5に支柱6を立て
、これに支持腕3個を付けて、−体に接続した尿供給口
1、濾過装置2.透析装置3を支持させ、下端の精製液
出口11から液を受はカップ4へ滴下させるものて、水
槽9の支持方法も任意にしている。
The device shown in the figure is the simplest one for general household use, with a support 6 erected on a base 5 on which a cup 4 is placed, and three supporting arms attached to it, and connected to the body. Urine supply port 1, filter device 2. The dialysis device 3 is supported and the liquid is dripped into the cup 4 from the purified liquid outlet 11 at the lower end, and the method of supporting the water tank 9 is also arbitrary.

透析には時間がかかるので、尿の変質を防ぐため、水槽
9内に氷塊を入れ、透析液として入口3aへ入る水の温
度を5〜6℃に保つようにしている。濾過装置2の外周
を水冷してもよい。
Since dialysis takes time, ice blocks are placed in the water tank 9 to keep the temperature of the water entering the inlet 3a as a dialysate at 5 to 6°C in order to prevent the urine from deteriorating. The outer periphery of the filter device 2 may be cooled with water.

透析装置3の尿側の圧力は重力だけによってもよいが、
透析速度を速めるため、供給口l内の尿の上面に空気圧
を加えるとか、おもりを載せたピストンで圧下するなど
してもよい0重力だけで尿を降下させる場合は、水槽9
の水面が、尿供給口1より低位にくるようにする。
The pressure on the urine side of the dialysis device 3 may be based only on gravity, but
To speed up the dialysis rate, air pressure may be applied to the upper surface of the urine in the supply port 1, or pressure may be lowered using a piston with a weight placed on it. If the urine is lowered only by zero gravity, the water tank 9
Make sure that the water level is lower than the urine supply port 1.

前述のように1図の透析装置3、水槽9、ホース1O1
10’を取りはずせば、これで第1発明も実施できる。
As mentioned above, the dialysis machine 3, water tank 9, hose 1O1 in Figure 1
If 10' is removed, the first invention can also be carried out.

第2発明は図とは無関係で、感染者から採った原を物理
的または化学的処理にかけて、尿中に生き残ったか、尿
路で加わった病原体を不活性化する。物理的方法には熱
処理と照射がある。
The second invention, unrelated to the diagram, involves subjecting the material taken from an infected person to physical or chemical treatments to inactivate pathogens that have survived in the urine or have been added in the urinary tract. Physical methods include heat treatment and irradiation.

熱処理は比較的熱に敏感な抗体、補体(56℃、20〜
30分の加熱で破壊)を損わない範囲で行なわねばなら
ない、従って適用できる病原体は限定される。
Heat treatment is for relatively heat-sensitive antibodies and complement (56℃, 20~
The pathogens that can be used are therefore limited.

照射は発展途上の処理法で、現在は種子の消毒に放射線
が使われている程度である。しかし今後の研究開発によ
り、尿中の唯一の生物である病原体を放射線、電子ビー
ム、イオンビーム等の照射で殺すか、少なくとも増殖不
能な状!!(不活性化)にすることは容易と思われる。
Irradiation is a treatment method that is still under development, and currently radiation is only used to disinfect seeds. However, future research and development will make it possible to kill pathogens, which are the only living organisms in urine, by irradiating them with radiation, electron beams, ion beams, etc., or at least make them incapable of multiplying! ! (inactivation) seems to be easy.

化学的処理により尿中の病原体を不活性化する方法は、
酸、アルカリを加えて病原体を殺した後、中和剤を加え
て中性に戻すとか、病原体が細菌なら抗生物質や特効薬
を加え、ウィルスなら、これを不活性化するインターフ
ェロン、その他、今後、開発される対ウィルス薬品を加
えればよい。
The method of inactivating pathogens in urine by chemical treatment is
After killing the pathogen by adding an acid or alkali, we add a neutralizing agent to return it to neutrality.If the pathogen is a bacteria, we add an antibiotic or a specific medicine, if it is a virus, we use interferon to inactivate it, and other things in the future. All you have to do is add anti-virus drugs that are developed.

〈発明の効果) この発明はウィルス、細菌、微生物等にむしばまれ、苦
しむ人類に、有効な対抗手段を与えたいとする発明者の
悲願をほぼ達成した。
<Effects of the Invention> This invention has almost achieved the inventor's wish to provide an effective countermeasure to humanity suffering from viruses, bacteria, microorganisms, etc.

人間や動物の体内に産生された免疫抗体は、感染した病
原体それぞれに対応したものであるから、この発明で採
取した抗体、補体含有物は、すべての感染症患者の自然
治癒力増強材となり得る。
Since the immune antibodies produced in the bodies of humans and animals correspond to each infectious pathogen, the antibodies and complement-containing substances collected by this invention can serve as a natural healing power enhancer for all infectious disease patients. obtain.

最も安価な材料である感染者、感染動物の尿から、その
病原体に極めて有効な免疫抗体、補体を、安価な採集装
置で採取する道を開いたこの発明は世界中の貧しい感染
症患者に、最低の医療費で最新、最適の医療を受けさせ
るものである。
This invention has opened the way for the collection of immune antibodies and complement, which are extremely effective against pathogens, from the urine of infected people and infected animals, which is the cheapest material, using an inexpensive collection device, and will benefit poor infectious disease patients around the world. , which allows people to receive the latest and most suitable medical care at the lowest medical costs.

【図面の簡単な説明】[Brief explanation of the drawing]

図はこの発明の免疫抗体、補体の採集ttMの一実施例
を示す0図中、lは尿供給口、2は濾過装置、3は透析
装置である。 特許出願人     高 野 鉄 雄 手続補正書(方側 昭和63年 9月 7日
The figure shows an embodiment of the immune antibody and complement collection ttM of the present invention. In the figure, 1 is a urine supply port, 2 is a filtration device, and 3 is a dialysis device. Patent Applicant Tetsuo Takano Procedural Amendment (September 7, 1988)

Claims (4)

【特許請求の範囲】[Claims] (1)感染者自身か、同じ病原体に感染した他人か動物
の尿を採り、その尿を、上記病原体を除去できる濾材で
濾過することを特徴とする免疫抗体、補体の採取法。
(1) A method for collecting immune antibodies and complement, which is characterized by collecting urine from an infected person or from another person or animal infected with the same pathogen, and filtering the urine through a filter medium capable of removing the pathogen.
(2)感染者自身か、同じ病原体に感染した他人か動物
の尿を取り、その尿中の上記病原体を、免疫抗体、補体
を損わないで行い得る物理的、または化学的処理により
、不活性化することを特徴とする免疫抗体、補体の採取
法。
(2) Taking the urine of the infected person or another person or animal infected with the same pathogen, and removing the pathogen in the urine by physical or chemical treatment that can be carried out without damaging immune antibodies or complement; A method for collecting immune antibodies and complement characterized by inactivation.
(3)請求項(1)または請求項(2)に記載の方法の
途中、または終りに、その尿を、尿素を除去し得る透析
装置に通すことを特徴とする免疫抗体、補体の採取法。
(3) Collection of immune antibodies and complement characterized by passing the urine through a dialysis machine capable of removing urea during or at the end of the method according to claim (1) or claim (2). Law.
(4)尿の供給口をもち、尿中の細菌、またはウィルス
まで除去し得る濾材を使った濾過装置、及び 上記濾過装置から出た尿を通すことにより、尿中の尿素
を拡散除去し得る透析装置、 を備えることを特徴とする免疫抗体、補体の採取装置。
(4) A filtration device that has a urine supply port and uses a filtering material that can remove bacteria or even viruses in the urine, and by passing the urine from the filtration device, urea in the urine can be diffused and removed. An immune antibody and complement collection device comprising: a dialysis device;
JP12487188A 1988-05-24 1988-05-24 Method and apparatus for collecting immune antibody and complement Pending JPH01294637A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12487188A JPH01294637A (en) 1988-05-24 1988-05-24 Method and apparatus for collecting immune antibody and complement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12487188A JPH01294637A (en) 1988-05-24 1988-05-24 Method and apparatus for collecting immune antibody and complement

Publications (1)

Publication Number Publication Date
JPH01294637A true JPH01294637A (en) 1989-11-28

Family

ID=14896161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12487188A Pending JPH01294637A (en) 1988-05-24 1988-05-24 Method and apparatus for collecting immune antibody and complement

Country Status (1)

Country Link
JP (1) JPH01294637A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118810A (en) * 1975-04-10 1976-10-19 Fujiwa Kako Kk A process for preparing proteolytic enzyme inhibitor from human urine
JPS51148088A (en) * 1975-06-16 1976-12-18 Mitsubishi Rayon Co Ltd Process for obtaining substances produced by organisms
JPS52117417A (en) * 1976-03-27 1977-10-01 Momoe Soeda Production of medicine used in hepatisis treatment
JPH01168623A (en) * 1987-12-24 1989-07-04 Seizo Funayama Production of secretor iga from feces and urine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118810A (en) * 1975-04-10 1976-10-19 Fujiwa Kako Kk A process for preparing proteolytic enzyme inhibitor from human urine
JPS51148088A (en) * 1975-06-16 1976-12-18 Mitsubishi Rayon Co Ltd Process for obtaining substances produced by organisms
JPS52117417A (en) * 1976-03-27 1977-10-01 Momoe Soeda Production of medicine used in hepatisis treatment
JPH01168623A (en) * 1987-12-24 1989-07-04 Seizo Funayama Production of secretor iga from feces and urine

Similar Documents

Publication Publication Date Title
US5284470A (en) Wearable, portable, light-weight artificial kidney
AU747412B2 (en) Septicaemia prevention and treatment system
DE69929986T2 (en) METHOD FOR REMOVING HIV AND OTHER VIRUSES FROM BLOOD
EP0684763B1 (en) Method and apparatus for treating a body fluid
US5628727A (en) Extracorporeal virioncidal apparatus
CN101124315A (en) Method for removal of viruses from blood by lectin affinity hemodialysis
US20080299212A1 (en) Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising Blood Plasma or Serum
CN100393371C (en) Device for extracorporal irradiation of a liquid containing bilirubin, and method therefor
WO1988010087A1 (en) Method for eradicating infectious contaminants in tissues
WO1994009833A9 (en) Wearable, portable, light-weight artificial kidney
WO1993000005A1 (en) Method for inactivating pathogens in a body fluid
CN102712503A (en) An immunoactivation blood perfusion filter for the treatment of malignant tumors
JP2020096971A (en) Blood filtering of inflammatory biomarkers to treat post-resuscitation syndrome
CN102600521A (en) Device and method for eliminating pathogens in blood
WO2009023332A2 (en) Device and method for purifying virally infected blood
US5383847A (en) Non-specific immune system enhancement
CN106267410B (en) HIV infection cell separator
JPH06511013A (en) Albumin-Iodine Preservation of Blood, Tissues and Biofluids
JPH01294637A (en) Method and apparatus for collecting immune antibody and complement
Siami et al. Cryofiltration apheresis in the treatment of cryoprecipitate induced diseases
ES2197483T3 (en) ELIMINATION OF DISINFECTANT COLORS.
ES2214671T3 (en) USE OF A NON-IONIC ABSORBING RESIN IN COMBINATION WITH THE SYSTEM KNOWN AS BIOARTIFICIAL LIVER.
JPH06510067A (en) Starch-iodine preservation of blood, tissues and biological fluids
CN103732271B (en) Detection and the method and apparatus of the disease such as treatment tumor and virus infection
EP1064960A2 (en) Hemodialysis assembly and method